These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Non-operative treatment of benign prostatic hyperplasia. Lal MM; Jain S J Indian Med Assoc; 1980 Nov; 75(9):174-6. PubMed ID: 6164733 [No Abstract] [Full Text] [Related]
7. Treatment of the enlarged benign prostate using local injections: a preliminary report. Milroy EJ West Indian Med J; 1968 Dec; 17(4):241-5. PubMed ID: 4183066 [No Abstract] [Full Text] [Related]
8. Experimental evaluation of injection therapy of enlarged prostate: Part I--Histopathological changes induced by intrao-prostatic injection of carbolic acid-acetic acid-glycerine mixture. Bhargava M; Kabra SG; Jhanwar J; Pande SK; Chaturvedi RP; Jain LK Indian J Exp Biol; 1977 Sep; 15(9):762-7. PubMed ID: 76605 [No Abstract] [Full Text] [Related]
9. Chemo-ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction. Ditrolio J; Patel P; Watson RA; Irwin RJ J Urol; 2002 May; 167(5):2100-3; discussion 2103-4. PubMed ID: 11956449 [TBL] [Abstract][Full Text] [Related]
10. Prostate botulinum A toxin injection--an alternative treatment for benign prostatic obstruction in poor surgical candidates. Kuo HC Urology; 2005 Apr; 65(4):670-4. PubMed ID: 15833506 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Antunes AA; Srougi M; Coelho RF; de Campos Freire G Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660 [TBL] [Abstract][Full Text] [Related]
12. Experimental evaluation of injection therapy of enlarged prostate: Part III--Effect of carbolic acid-acetic acid-glycerine mixture on vessels. Jhanwar J; Kabra SG; Jhalla GS; Chaturvedi RP; Sharma KK; Bhargava M Indian J Exp Biol; 1977 Sep; 15(9):772-5. PubMed ID: 76607 [No Abstract] [Full Text] [Related]
13. Prostatic stents for the treatment of benign prostatic hyperplasia. Vanderbrink BA; Rastinehad AR; Badlani GH Curr Opin Urol; 2007 Jan; 17(1):1-6. PubMed ID: 17143103 [TBL] [Abstract][Full Text] [Related]
14. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms. Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690 [TBL] [Abstract][Full Text] [Related]
15. Re: Ethanol injection therapy of the prostate for benign prostatic hyperplasia: preliminary report on application of a new technique. Zvara P; Plante MK J Urol; 2000 Feb; 163(2):552-3. PubMed ID: 10647683 [No Abstract] [Full Text] [Related]
16. Phase I/II examination of transurethral ethanol ablation of the prostate for the treatment of symptomatic benign prostatic hyperplasia. Plante MK; Marks LS; Anderson R; Amling C; Rukstalis D; Badlani G; Getlin L; Vang E J Urol; 2007 Mar; 177(3):1030-5; discussion 1035. PubMed ID: 17296405 [TBL] [Abstract][Full Text] [Related]
18. Maintenance of clinical efficacy with finasteride therapy for 24 months in patients with benign prostatic hyperplasia. The Finasteride Study Group. Stoner E Arch Intern Med; 1994 Jan; 154(1):83-8. PubMed ID: 7505563 [TBL] [Abstract][Full Text] [Related]